At North Quest Clinical Talent, we provide comprehensive U.S. FDA regulatory and medical device compliance support to help medical device manufacturers, biotechnology companies, pharmaceutical organizations, and healthcare innovators navigate the complex U.S. regulatory landscape.
Our regulatory professionals support organizations throughout the medical device lifecycle—from product classification and regulatory strategy to premarket submissions, FDA interactions, establishment registration, quality-system support, compliance, and regulatory responses.
We combine regulatory expertise, clinical research knowledge, and practical industry experience to help organizations develop clear regulatory pathways, prepare high-quality documentation, and address FDA requirements efficiently.
Regulatory Expertise. Clinical Insight. Smarter Pathways to the U.S. Market.
We develop practical U.S. regulatory strategies based on your device, intended use, risk profile, technology, and commercialization objectives. Our support can include regulatory pathway assessment, submission planning, documentation strategy, and regulatory gap identification.
We evaluate your medical device and help determine the appropriate U.S. regulatory pathway.
Depending on the device and its characteristics, potential pathways may include 510(k), De Novo, PMA, or applicable exemptions. FDA explains that 510(k), De Novo, and PMA pathways are generally selected based on device risk and the availability of an appropriate predicate.
Our team provides comprehensive support for 510(k) premarket notification submissions, including regulatory strategy, documentation development, submission preparation, and review.
We help organize the required technical and regulatory information into a structured submission designed to support FDA review. FDA identifies Traditional, Special, and Abbreviated 510(k) formats and provides specific content requirements for 510(k) submissions.
For eligible novel medical devices without an appropriate legally marketed predicate, we provide De Novo Classification Request support. Our services can include pathway assessment, regulatory strategy, documentation preparation, submission review, and response support. FDA describes De Novo as a risk-based pathway that can classify certain novel devices into Class I or Class II.
We help organizations prepare for interactions with FDA, including:
Our goal is to help clients enter regulatory discussions with a clear strategy and well-structured questions.
We support the preparation and review of FDA regulatory submissions to help ensure documentation is complete, consistent, organized, and aligned with applicable requirements.
Our review process focuses on:
FDA review may generate requests for additional information or clarification.
Our team can support organizations in preparing structured responses, reviewing supporting documentation, coordinating subject-matter input, and maintaining consistency across regulatory communications.
We provide support for U.S. medical device establishment registration and device listing, including preparation and review of required information.
FDA requires applicable medical device establishments to register annually and generally requires establishments to list the devices they manufacture and the activities performed on those devices.
Important: FDA registration or device listing does not itself represent FDA approval or clearance of a company or product.
We support organizations with Unique Device Identification (UDI) and Global Unique Device Identification Database (GUDID) activities.
Our services can include:
FDA’s UDI framework requires applicable device labels and packages to include a unique device identifier, subject to applicable exceptions or alternatives, and requires specified information to be submitted to GUDID.
For eligible clients, we provide U.S. regulatory representation support to facilitate communication and coordination related to U.S. regulatory activities.
The exact scope of representation will be defined based on the client’s regulatory requirements and written engagement.
Where legally permitted and expressly agreed upon, we can provide or coordinate U.S. Agent services for applicable foreign medical device companies.
The specific responsibilities and scope will be established in writing based on the client’s regulatory obligations.
We help medical device organizations strengthen their quality and compliance processes through structured regulatory and quality-system support.
Our services may include:
We provide regulatory support related to ISO 13485-based medical device quality management systems, including documentation review, quality-system support, regulatory alignment, and readiness activities.
Our role is to help organizations better understand and address regulatory and quality requirements as they prepare for commercialization, audits, or other regulatory activities.
We support the development and review of regulatory documentation associated with medical device risk management and product compliance.
Our support can include:
Receiving an FDA Form 483, warning letter, or other regulatory communication can create significant operational and compliance pressure.
Our regulatory professionals can support organizations in:
Final regulatory responses should be reviewed and approved by the client’s appropriate regulatory, quality, legal, and subject-matter professionals.
Regulatory requirements and expectations can evolve. Our Regulatory Intelligence Services help organizations assess regulatory pathways, identify relevant requirements, and make better-informed regulatory decisions.
Our support includes:
Our management and professional team brings experience from the clinical research and life sciences industry.
Our services are designed specifically to support organizations navigating the U.S. medical device regulatory environment.
From regulatory strategy and classification through submissions, FDA correspondence, compliance, and inspection readiness.
Engage us for a specific regulatory project, ongoing regulatory support, or broader medical device compliance requirements.
We emphasize accuracy, consistency, documentation quality, and regulatory readiness throughout each engagement.
Our U.S. FDA regulatory services are designed for:
Entering and maintaining a presence in the U.S. medical device market requires careful regulatory planning, high-quality documentation, and ongoing compliance.
North Quest Clinical Talent helps organizations navigate these requirements with practical regulatory support, clinical research expertise, and flexible engagement models.
Whether you are developing a new medical device, preparing a 510(k), exploring a De Novo pathway, preparing for an FDA meeting, establishing your U.S. regulatory presence, or strengthening inspection readiness, our team can support your regulatory objectives.